TORONTO — Canadian cannabis stocks soared Tuesday afternoon after The Associated Press reported the U.S. Drug Enforcement Agency will move to reclassify marijuana as a less dangerous drug.
Canopy Growth Corp. surged 49 per cent after the announcement, while Aurora Cannabis Inc. and Tilray Brands Inc. soared 32 and 39 per cent, respectively. The Associated Press, citing five sources familiar with the matter, reported the DEA's proposal would recognize the medical uses of cannabis and acknowledge it has less potential for abuse than other, more dangerous drugs.Currently, marijuana is listed as a Schedule I drug in the U.S., alongside heroin and LSD, but would be reclassified as a Schedule III drug, alongside ketamine and some anabolic steroids.
The reclassification of the drug in the U.S. could lessen risks for cannabis companies that operate south of the border and potentially improve investor appetite for cannabis stocks.The Canadian Press
مصر أحدث الأخبار, مصر عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
مصدر: YahooFinanceCA - 🏆 47. / 63 اقرأ أكثر »
مصدر: YahooFinanceCA - 🏆 47. / 63 اقرأ أكثر »
مصدر: YahooFinanceCA - 🏆 47. / 63 اقرأ أكثر »